🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is being done to look at how tucatinib could affect the way othe...
Status
Completed
Location
Covance Clinical Research Unit
Start Date
2018-09-17
Trial ID
NCT03723395
Treatments Being Tested
The goal of this study is to evaluate the efficacy and safety of tucatinib ...
Status
Active Not Recruiting
Location
Aichi Cancer Center Hospital ( Site 1013)
Start Date
2021-04-08
Trial ID
NCT04721977
Treatments Being Tested
Women or men with HER2-positive, metastatic breast cancer, who have progres...
Status
Terminated
Location
Coffs Harbour Health Campus
Start Date
2023-03-07
Trial ID
NCT04789096
Treatments Being Tested
A phase 2 non-randomized study to assess the safety and efficacy of the com...
Status
Terminated
Location
University of Alabama at Birmingham
Start Date
2019-02-20
Trial ID
NCT03501979
Treatments Being Tested
The goal of this clinical trial is to evaluate the efficacy of tucatinib an...
Status
Recruiting
Location
Institut Bergonié
Start Date
2023-12-18
Trial ID
NCT05800275
Treatments Being Tested
DESTINY-Breast07 will investigate the safety, tolerability, and anti-tumour...
Status
Active Not Recruiting
Location
Research Site
Start Date
2020-12-28
Trial ID
NCT04538742
Treatments Being Tested
This study is being done to compare the pharmacokinetics (PK) and safety/to...
Status
Completed
Location
PAREXEL International, Early Phase Clinical Unit - Los Angeles
Start Date
2019-05-08
Trial ID
NCT03914755
Treatments Being Tested
The purpose of this study is to test the safety and effectiveness of a sequ...
Status
Recruiting
Location
Dana-Farber Cancer Institute
Start Date
2024-08-08
Trial ID
NCT06439693
The primary purpose of this study is to characterize the safety and tolerab...
Status
Active Not Recruiting
Location
Harbin Medical University Cancer Hospital
Start Date
2022-06-29
Trial ID
NCT05382364
Treatments Being Tested
The aims of this study are to evaluate if an intensified adjuvant treatment...
Status
Suspended
Location
Fondazione Casa Sollievo della Sofferenza
Start Date
2023-05-17
Trial ID
NCT05062889
Treatments Being Tested